The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients

Leukemia Research

Volumn 33, Issue 8, 2009, Pages 1029-1038

  Liu, Dandan ^a   Chen, Zixing ^a   Xue, Yongquan ^a   Lu, Dingwei ^a   Zhou, Youning ^a   Gong, Jingxia ^a   Wu, Weilin ^a   Liang, Jianying ^a   Ma, Qinfen ^a   Pan, Jinlan ^a   Wu, Yafang ^a   Wang, Yong ^a   Zhang, Jun ^a   Shen, Juan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cytogenetical abnormality; Diagnosis; Dysplasia; MDS

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; GRANULOCYTE; HUMAN; KARYOTYPE; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; REFRACTORY ANEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES;

EID: 65549111096     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.02.011     Document Type: Article

References (20)

1. Mufti G., Bennett J.M., Goasguen J., Bain B.J., Baumann I., Brunning R., et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 93 (2008) 1712-1717
2. Pagnucco G., Giambanco C., and Gervasi F. The role of flow cytometric immunophenotyping in myelodysplastic syndromes. Ann NY Acad Sci 1089 (2006) 383-394
3. Chen B., Zhao W.L., Jin J., Xue Y.Q., Cheng X., Chen X.T., et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19 (2005) 767-775
4. + cells in low-grade myelodysplastic syndromes. Blood 108 (2006) 1037-1044
5. Valent P., Horny H.P., Bennett J.M., Fonatsch C., Germing U., Greenberg P., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 31 6 (2007) 727-736
6. Font P., Subira D., Loscertales J., Arranz E., Alonso A., Perez-Saenz M.A., et al. Idiopathic cytopenia of undetermined significance (ICUS): impact of flow cytometry immunophenotyping (FCI) in the diagnosis of myelodysplastic syndrome (MDS) when morphology is not conclusive. Blood 110 (2007) 2467 (ASH Annual Meeting Abstracts)
7. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D., Gralnick H.R., et al. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
8. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France p. 61-73
9. Cantù Rajnoldi A., Fenu S., Kerndrup G., van Wering E.R., Niemeyer C.M., Baumann I., et al. Evaluation of dysplastic features in myelodysplastic syndromes: experience from the morphology group of the European Working Group of MDS in Childhood (EWOG-MDS). Ann Hematol 84 (2005) 429-433
10. Miguel A., Orero M., Simon R., Collado R., Perez P.L., Pacios A., et al. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia. Lab Hematol 13 (2007) 98-102
11. Mitelman F, Karger S. ISCN (1995): An International System for Human Cytogenetic Nomenclature. Ed. Guidelines for cancer cytogenetics. New York: Karger; 1995.
12. Bando S., Niiya T., Murase M., and Makino H. A feature of hematological findings in myelodysplastic syndromes. Rinsho Byori 46 (1998) 790-795
13. Aul C., Giagounidis A., and Germing U. Bone marrow morphology and classification systems in myelodysplastic syndromes. Cancer Treat Rev 33 Suppl. 1 (2007) S2-S5
14. Yashige H., Horiike S., Taniwaki M., Misawa S., and Abe T. Micronuclei and nuclear abnormalities observed in erythroblasts in myelodysplastic syndromes and in de novo acute leukemia after treatment. Acta Haematol 101 (1999) 32-40
15. Vila L., Charrin C., Archimbaud E., Treille-Ritouet D., Fraisse J., Felman P., et al. Correlations between cytogenetics and morphology in myelodysplastic syndromes. Blut 60 (1990) 223-227
16. Boultwood J., Fidler C., Strickson A.J., Watkins F., Gama S., Kearney L., et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood 99 (2002) 4638-4641
17. Hirai H. Molecular mechanisms of myelodysplastic syndrome. Jpn J Clin Oncol 33 (2003) 153-160
18. Tomonaga M. Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology. Rinsho Byori 53 (2005) 54-60
19. Shetty V.T., Mundle S.D., and Raza A. Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented or apoptotic neutrophil?. Blood 98 (2001) 1273-1275
20. Kobayashi Y., Uoshima N., Kimura S., Tanaka K., Wada K., Ozawa M., et al. Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients. Int J Hematol 61 (1995) 117-122